EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI : Part 2—Ex vivo imaging: Added value and acquisition

Kurt G Schilling iD, Francesco Grussu, Andrada Ianus, Brian Hansen, Amy F D Howard, Rachel L C Barrett, Manisha Aggarwal, Stijn Michielse, Fatima Nasrallah, Warda Syeda, Nian Wang, Jelle Veraart und 46 weitere

Magnetic Resonance in Medicine · 2025-06 · 93 (6) · 2535-2560

DOI: 10.1002/mrm.30435 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Magnetic Resonance in Medicine, online erschienen am 04.03.2025. Verfasst von Kurt G Schilling und 57 weiteren Autor:innen. Beteiligte Einrichtung: Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Brain, Diffusion Magnetic Resonance Imaging, Image Processing, Computer-Assisted. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, Wellcome Trust, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The value of preclinical diffusion MRI (dMRI) is substantial. While dMRI enables in vivo non‐invasive characterization of tissue, ex vivo dMRI is increasingly being used to probe tissue microstructure and brain connectivity. Ex vivo dMRI has several experimental advantages including higher SNR and spatial resolution compared to in vivo studies, and enabling more advanced diffusion contrasts for improved microstructure and connectivity characterization. Another major advantage of ex vivo dMRI is the direct comparison with histological data, as a crucial methodological validation. However, there are a number of considerations that must be made when performing ex vivo experiments. The steps from tissue preparation, image acquisition and processing, and interpretation of results are complex, with many decisions that not only differ dramatically from in vivo imaging of small animals, but ultimately affect what questions can be answered using the data. This work represents “Part 2” of a three‐part series of recommendations and considerations for preclinical dMRI. We describe best practices for dMRI of ex vivo tissue, with a focus on the value that ex vivo imaging adds to the field of dMRI and considerations in ex vivo image acquisition. We first give general considerations and foundational knowledge that must be considered when designing experiments. We briefly describe differences in specimens and models and discuss why some may be more or less appropriate for different studies. We then give guidelines for ex vivo protocols, including tissue fixation, sample preparation, and MR scanning. In each section, we attempt to provide guidelines and recommendations, but also highlight areas for which no guidelines exist (and why), and where future work should lie. An overarching goal herein is to enhance the rigor and reproducibility of ex vivo dMRI acquisitions and analyses, and thereby advance biomedical knowledge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainDiffusion Magnetic Resonance ImagingImage Processing, Computer-AssistedAnimalsHumansReproducibility of ResultsSignal-To-Noise Ratio

Stichwörter der Autor:innen

acquisitionbest practicesdiffusion MRIdiffusion tensorex vivomicrostructureopen sciencepreclinicalprocessingtractography

Autor:innen und Institutionen

  • Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Vanderbilt University Institute of Imaging Science, Vanderbilt University, Nashville, Tennessee, USA.
  • Radiomics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Queen Square MS Centre, Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London, UK.
  • Champalimaud Research, Champalimaud Foundation, Lisbon, Portugal.
  • School of Biomedical Engineering and Imaging Sciences, King's College London, London.

ORCID-Profile: Kurt G Schilling, Ileana O Jelescu

Förderung

  • NIBIB NIH HHS
  • Wellcome Trust
  • NIH HHS
  • NIDA NIH HHS
  • NCI NIH HHS
  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institutes of Health

Zitieren

APA

Schilling, K. G., Grussu, F., Ianus, A., Hansen, B., Howard, A. F. D., Barrett, R. L. C., Aggarwal, M., Michielse, S., Nasrallah, F., Syeda, W., Wang, N., Veraart, J., Roebroeck, A., Bagdasarian, A. F., Eichner, C., Sepehrband, F., Zimmermann, J., Soustelle, L., Bowman, C., …, & Jelescu, I. O. (2025). Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI : Part 2—Ex vivo imaging: Added value and acquisition. Magnetic Resonance in Medicine, 93(6), 2535-2560. https://doi.org/10.1002/mrm.30435

Vancouver

Schilling KG, Grussu F, Ianus A, Hansen B, Howard AFD, Barrett RLC, et al. Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI : Part 2—Ex vivo imaging: Added value and acquisition. Magnetic Resonance in Medicine. 2025;93(6):2535-2560. doi:10.1002/mrm.30435

BibTeX
@article{Schilling2025,
  author = {Schilling, Kurt G and Grussu, Francesco and Ianus, Andrada and Hansen, Brian and Howard, Amy F D and Barrett, Rachel L C and Aggarwal, Manisha and Michielse, Stijn and Nasrallah, Fatima and Syeda, Warda and Wang, Nian and Veraart, Jelle and Roebroeck, Alard and Bagdasarian, Andrew F and Eichner, Cornelius and Sepehrband, Farshid and Zimmermann, Jan and Soustelle, Lucas and Bowman, Christien and Tendler, Benjamin C and Hertanu, Andreea and Jeurissen, Ben and Verhoye, Marleen and Frydman, Lucio and van de Looij, Yohan and Hike, David and Dunn, Jeff F and Miller, Karla and Landman, Bennett A and Shemesh, Noam and Anderson, Adam and McKinnon, Emilie and Farquharson, Shawna and Dell'Acqua, Flavio and Pierpaoli, Carlo and Drobnjak, Ivana and Leemans, Alexander and Harkins, Kevin D and Descoteaux, Maxime and Xu, Duan and Huang, Hao and Santin, Mathieu D and Grant, Samuel C and Obenaus, Andre and Kim, Gene S and Wu, Dan and Le Bihan, Denis and Blackband, Stephen J and Ciobanu, Luisa and Fieremans, Els and Bai, Ruiliang and Leergaard, Trygve B and Zhang, Jiangyang and Dyrby, Tim B and Johnson, G Allan and Cohen-Adad, Julien and Budde, Matthew D and Jelescu, Ileana O},
  title = {Considerations and recommendations from the ISMRM diffusion study group for preclinical diffusion MRI : Part 2—Ex vivo imaging: Added value and acquisition},
  journal = {Magnetic Resonance in Medicine},
  year = {2025},
  volume = {93},
  number = {6},
  pages = {2535--2560},
  doi = {10.1002/mrm.30435}
}
Kostenlos starten →